Pardes Biosciences Inc (PRDS)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
2.16 unch (unch) 08/30/23 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 2.16 unch (unch) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -96,634 | -38,518 | N/A | N/A | N/A |
| Depreciation Amortization | -1,059 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,779 | 756 | N/A | N/A | N/A |
| Other Working Capital | 15,157 | 379 | N/A | N/A | N/A |
| Other Operating Activity | 7,781 | 465 | 0 | 0 | 0 |
| Operating Cash Flow | $-71,976 | $-36,918 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -138,201 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 1,180 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-137,021 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 85,000 | N/A | N/A | N/A |
| Debt Repayment | N/A | -10,000 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 198,937 | N/A | N/A | N/A |
| Other Financing Activity | -397 | 28,249 | 0 | 0 | 0 |
| Financing Cash Flow | $-397 | $302,186 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 268,678 | 3,410 | N/A | N/A | N/A |
| End Cash Position | 59,284 | 268,678 | N/A | N/A | N/A |
| Net Cash Flow | $-209,394 | $265,268 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -71,976 | -36,918 | N/A | N/A | N/A |
| Free Cash Flow | -71,976 | -36,918 | 0 | 0 | 0 |